Ken Griffin
LRMR icon

Ken Griffin’s Larimar Therapeutics LRMR Stock Holding History

Ken Griffin’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
+32,200
New +$129K ﹤0.01% 11715
2025
Q4 		– Sell
-288,200
Closed -$931K – 13491
2025
Q3 		$931K Buy
288,200
+238,100
+475% +$893K ﹤0.01% 7681
2025
Q2 		$145K Sell
50,100
-1,500
-3% -$3.47K ﹤0.01% 10993
2025
Q1 		$111K Buy
51,600
+24,400
+90% +$77.1K ﹤0.01% 11318
2024
Q4 		$105K Buy
27,200
+3,100
+13% +$20.5K ﹤0.01% 11408
2024
Q3 		$158K Sell
24,100
-12,400
-34% -$99.7K ﹤0.01% 10501
2024
Q2 		$265K Sell
36,500
-72,200
-66% -$553K ﹤0.01% 9386
2024
Q1 		$825K Buy
108,700
+106,400
+4,626% +$829K ﹤0.01% 7345
2023
Q4 		$10.5K Sell
2,300
-2,100
-48% -$7.08K ﹤0.01% 13103
2023
Q3 		$17.4K Buy
4,400
+2,200
+100% +$8.32K ﹤0.01% 12732
2023
Q2 		$6.89K Buy
+2,200
New +$8.98K ﹤0.01% 13398
2023
Q1 		– Sell
-100
Closed -$413 – 15155
2022
Q4 		$413 Buy
+100
New +$341 ﹤0.01% 14663
2022
Q3 		– Sell
-10,200
Closed -$20K – 13186
2022
Q2 		$20K Sell
10,200
-7,600
-43% -$22.5K ﹤0.01% 12405
2022
Q1 		$72K Buy
+17,800
New +$116K ﹤0.01% 12554
2016
Q1 		– Sell
-367
Closed -$28K – 7443
2015
Q4 		$28K Hold
367
– – ﹤0.01% 7703
2015
Q3 		$141K Buy
+367
New +$165K ﹤0.01% 6573

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Ken Griffin's LRMR Position: Q1 2026 in Review

Ken Griffin reduced its Larimar Therapeutics (LRMR) stake by 62% in Q1 2026, selling an estimated $3.39M and leaving 519,132 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #5758.

Ken Griffin first reported a position in LRMR in Q2 2014 and has held it in 31 quarters since. The position peaked at $12.2M in Q3 2018. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Ken Griffin held 519,132 shares of Larimar Therapeutics worth $2.34M as of Q1 2026.
  • Ken Griffin sold 847,618 Larimar Therapeutics shares in Q1 2026, an estimated $3.39M.
  • Larimar Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #5758 holding.
  • Ken Griffin first reported a position in Larimar Therapeutics in Q2 2014 and has held it in 31 quarters since.
  • Ken Griffin's Larimar Therapeutics position peaked at $12.2M in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.